Drug Approval | August 08, 2023
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
The inspection closed with zero observations and a classification of No Action Indicated
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
The product is being launched in August 2023
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Aims to foster a Resilient and Sustainable Healthcare Ecosystem
Subscribe To Our Newsletter & Stay Updated
